Cite
HARVARD Citation
Thomas, G. et al. (n.d.). 0017: A Gog Phase III Trial to Evaluate Maintaining Hemoglobin (HGB) ≥120G/L with Erythropoietin (EPO) During Chemoradiation (Ct/Rt) for Cervical Cancer. International journal of gynecological cancer. pp. 603-604. [Online].